Method for promoting immunotherapies
AssigneeFresenius Medical Care Deutschland GmbH
InventorsMartin Hepper, Hans Peter Leinenbach, Frank Nocken
Life of this patent
Estimating the term…
Abstract
The present invention relates to an ex vivo method for increasing the effectiveness of antibodies and Fcγ receptor-binding active ingredients, comprising the steps of: a) preparing a blood sample of a patient; b) subjecting the blood sample to an immunoapheresis; c) administering a therapeutically effective antibody or an Fcγ receptor-binding active ingredient to the patient.
Claims43
Ex-vivo method for increasing the effectiveness of antibodies and Fcγ receptor-binding active ingredients, comprising the steps of:
- a) preparing a blood sample of a patient;
- b) subjecting the blood sample to an immunoapheresis;
- c) administering a therapeutically effective antibody or an Fcγ receptor-binding active ingredient to a patient.
Use of a combination of one or more medicinal products together with FcR-binding immunoglobulins, fragments of immunoglobulins or fusion proteins, to prepare a medicament for the treatment of cancer and/or autoimmune diseases and/or of patients who have had a transplant and/or for vaccination against viruses, wherein the treatment comprises the steps of:
- a) preparing a blood sample of a patient;
- b) subjecting the blood sample to an immunoapheresis;
- c) administering a therapeutically effective antibody to the patient.
Use of specific ligands for autologous antibodies with Fcγ receptor-binding regions to prepare a column which has the specific ligand coupled to it, for the treatment of a patient with Fcγ receptor-binding active ingredients, wherein the treatment comprises the steps of:
- a) preparing a blood sample of a patient;
- b) subjecting the blood sample to an immunoapheresis;
- c) administering an Fcγ receptor-binding active ingredient to the patient.
Use of specific ligands for autologous antibodies to prepare a column which has the ligand coupled to it, for the treatment of a patient with therapeutic antibodies, wherein the treatment comprises the steps of:
- a) preparing a blood sample of a patient;
- b) subjecting the blood sample to an immunoapheresis;
- c) administering a therapeutically effective antibody to the patient.
Use of specific ligands for cancer-associated antigens soluble in blood samples to prepare a column which has the ligand coupled to it, for the treatment of a patient with therapeutic antibodies, wherein the treatment comprises the steps of:
- a) preparing a blood sample of a patient;
- b) subjecting the blood sample to an immunoapheresis;
- c) administering a therapeutically effective antibody to the patient.
Use of Fcγ receptor-binding active ingredients to prepare a medicament for the treatment of cancer and/or autoimmune diseases and/or of patients who have had a transplant and/or for vaccination against viruses, wherein the treatment comprises the steps of:
- a) preparing a blood sample of a patient;
- b) subjecting the blood sample to an immunoapheresis;
- c) administering the medicament to the patient.
Dependencies are inferred from the claim text.